Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y Stage

Background. There are still no clearly proven methods to slow down or stop the progression of Parkinson’s disease (PD). Thus, improving the quality of life (QoL) of patients with PD becomes of primary importance. Autonomic dysfunction and its symptoms are known to worsen the quality of life in PD, b...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Pilipovich, O. V. Vorob’eva, S. A. Makarov, N. N. Shindryaeva, Yu D. Vorob’eva
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2022/1571801
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562342710214656
author A. A. Pilipovich
O. V. Vorob’eva
S. A. Makarov
N. N. Shindryaeva
Yu D. Vorob’eva
author_facet A. A. Pilipovich
O. V. Vorob’eva
S. A. Makarov
N. N. Shindryaeva
Yu D. Vorob’eva
author_sort A. A. Pilipovich
collection DOAJ
description Background. There are still no clearly proven methods to slow down or stop the progression of Parkinson’s disease (PD). Thus, improving the quality of life (QoL) of patients with PD becomes of primary importance. Autonomic dysfunction and its symptoms are known to worsen the quality of life in PD, but the degree of this influence is underinvestigated. Particularly, impacts of the separate significant gastrointestinal symptoms, such as dyspepsia, constipation, and abdominal pain, in PD should be more precisely evaluated with the help of specific scales. Objective. To assess the impacts of gastrointestinal dysfunction and its symptoms on PD patient’s QoL using PDQ-39. Methods. 111 PD patients in the I-III Hoehn and Yahr (H&Y) stage were enrolled in the study. The following scales were applied: UPDRS III, PDQ-39, GSRS, GDSS, MMSE, BDI, STAI-S, and STAI-T. Results. The linear regression model showed that the PDQ-39 SI depended on summary assessments GSRS-SI (β = 0.333, p<0.001), BDI (β = 0.463, p<0.001), and UPDRS III (β = 0.163, p<0.05). The use of the stepwise method, adding GSRS-SI and UPDRS III scores to the BDI predictor, improved the model (R2 increased from 0.454 to 0.574). The investigation of GSRS domain’s influence revealed that PDQ-39 SI had a significant correlation with almost all of them, but the regression analysis showed significant QoL impacts of only two factors: constipation and abdominal pain (β = 0.288, p<0.01 and β = 0.243, p<0.05 accordingly). Conclusions. Our results suggest a considerable negative influence of depression and gastrointestinal dysfunction (especially constipation and abdominal pain) on QoL of patients with PD. Their impact on QoL in patients with I-III H&Y stages of PD is more significant than that of motor symptoms. Therefore, the correction of depression and gastrointestinal dysfunction should be prioritized in PD therapy.
format Article
id doaj-art-f7e22561b0f548ffadd3a219c6b47ebd
institution Kabale University
issn 2042-0080
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-f7e22561b0f548ffadd3a219c6b47ebd2025-02-03T01:22:56ZengWileyParkinson's Disease2042-00802022-01-01202210.1155/2022/1571801Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y StageA. A. Pilipovich0O. V. Vorob’eva1S. A. Makarov2N. N. Shindryaeva3Yu D. Vorob’eva4Department of Nervous DiseaseDepartment of Nervous DiseaseDepartment of Nervous DiseaseDepartment of Nervous DiseaseDepartment of Nervous DiseaseBackground. There are still no clearly proven methods to slow down or stop the progression of Parkinson’s disease (PD). Thus, improving the quality of life (QoL) of patients with PD becomes of primary importance. Autonomic dysfunction and its symptoms are known to worsen the quality of life in PD, but the degree of this influence is underinvestigated. Particularly, impacts of the separate significant gastrointestinal symptoms, such as dyspepsia, constipation, and abdominal pain, in PD should be more precisely evaluated with the help of specific scales. Objective. To assess the impacts of gastrointestinal dysfunction and its symptoms on PD patient’s QoL using PDQ-39. Methods. 111 PD patients in the I-III Hoehn and Yahr (H&Y) stage were enrolled in the study. The following scales were applied: UPDRS III, PDQ-39, GSRS, GDSS, MMSE, BDI, STAI-S, and STAI-T. Results. The linear regression model showed that the PDQ-39 SI depended on summary assessments GSRS-SI (β = 0.333, p<0.001), BDI (β = 0.463, p<0.001), and UPDRS III (β = 0.163, p<0.05). The use of the stepwise method, adding GSRS-SI and UPDRS III scores to the BDI predictor, improved the model (R2 increased from 0.454 to 0.574). The investigation of GSRS domain’s influence revealed that PDQ-39 SI had a significant correlation with almost all of them, but the regression analysis showed significant QoL impacts of only two factors: constipation and abdominal pain (β = 0.288, p<0.01 and β = 0.243, p<0.05 accordingly). Conclusions. Our results suggest a considerable negative influence of depression and gastrointestinal dysfunction (especially constipation and abdominal pain) on QoL of patients with PD. Their impact on QoL in patients with I-III H&Y stages of PD is more significant than that of motor symptoms. Therefore, the correction of depression and gastrointestinal dysfunction should be prioritized in PD therapy.http://dx.doi.org/10.1155/2022/1571801
spellingShingle A. A. Pilipovich
O. V. Vorob’eva
S. A. Makarov
N. N. Shindryaeva
Yu D. Vorob’eva
Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y Stage
Parkinson's Disease
title Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y Stage
title_full Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y Stage
title_fullStr Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y Stage
title_full_unstemmed Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y Stage
title_short Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y Stage
title_sort gastrointestinal dysfunction impact on life quality in a cohort of russian patients with parkinson s disease i iii h y stage
url http://dx.doi.org/10.1155/2022/1571801
work_keys_str_mv AT aapilipovich gastrointestinaldysfunctionimpactonlifequalityinacohortofrussianpatientswithparkinsonsdiseaseiiiihystage
AT ovvorobeva gastrointestinaldysfunctionimpactonlifequalityinacohortofrussianpatientswithparkinsonsdiseaseiiiihystage
AT samakarov gastrointestinaldysfunctionimpactonlifequalityinacohortofrussianpatientswithparkinsonsdiseaseiiiihystage
AT nnshindryaeva gastrointestinaldysfunctionimpactonlifequalityinacohortofrussianpatientswithparkinsonsdiseaseiiiihystage
AT yudvorobeva gastrointestinaldysfunctionimpactonlifequalityinacohortofrussianpatientswithparkinsonsdiseaseiiiihystage